Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several acquired immune deficiency syndrome-related malignancies, including Kaposi's sarcoma, primary effusion lymphoma (PEL) and a subset of multicentric Castleman's disease 1 . Control of viral lytic replication is essential for KSHV latency, evasion of the host immune system and induction of tumours 1 . Here, we show that deletion of a 14 microRNA (miRNA) cluster from the KSHV genome significantly enhances viral lytic replication as a result of reduced NF-κB activity. The miRNA cluster regulates the NF-κB pathway by reducing expression of IκBα protein, an inhibitor of NF-κB complexes. Computational and miRNA seed mutagenesis analyses were used to identify KSHV miR-K1, which directly regulates the IκBα protein level by targeting the 3´UTR of its transcript. Expression of miR-K1 is sufficient to rescue NF-κB activity and inhibit viral lytic replication, whereas inhibition of miR-K1 in KSHV-infected PEL cells has the opposite effect. Thus, KSHV encodes an miRNA to control viral replication by activating the NF-κB pathway. These results demonstrate an important role for KSHV miRNAs in regulating viral latency and lytic replication by manipulating the host survival pathway.
. These miRNAs are located in the latent genomic locus and are expressed during viral latency and in Kaposi's sarcoma tumours [2] [3] [4] [5] [6] . Several KSHV miRNAs target cellular genes, and thus might have roles in the pathogenesis of KSHV-induced malignancies [7] [8] [9] [10] [11] [12] . However, their roles in viral infection and replication remain unclear.
To determine the function of KSHV miRNAs in the viral lifecycle, we generated a viral mutant, ΔmiRNA with a cluster of 14 miRNAs deleted (except miR-K10a/b and miR-K12) and its revertant ΔmiRNA_rt ( Supplementary  Information, Fig. S1 ). The recombinant viruses were reconstituted in 293T cells, which can be efficiently transfected with large viral DNA genomes, support persistent infection and replication by KSHV and are the only cell type used successfully in conjunction with the KSHV genetic system so far 13, 14 . ΔmiRNA and wild-type virus cells showed no difference in morphology, latent nuclear antigen (LANA) staining pattern and genome copy number per cell ( Fig. 1a, left) . Expression of the latent gene LANA was also unchanged in uninduced cells after the miRNA cluster deletion but was marginally higher in wild-type than ΔmiRNA cells following lytic induction (Fig. 1a, left) . Immunofluorescence staining showed that wild-type and ΔmiRNA cells had similar expression levels of LANA protein ( Supplementary Information,  Fig. S2b ). In contrast, the expression level of replication and transcription activator (RTA), which activates viral lytic replication, was 4.2-fold higher in ΔmiRNA than wild-type cells (Fig. 1a, middle) . Although the RTA level in wild-type cells was increased 3.2-fold after lytic induction, it remained 2.3-fold higher in ΔmiRNA cells. Similar results were observed with KSHV late lytic protein major capsid protein (MCP; Fig. 1a, right) . Examination of expression kinetics showed that ΔmiRNA cells had significantly higher expression levels of both RTA and MCP throughout the entire lytic induction period (Fig. 1b, c) . In addition, RTA promoter activity was 1.6-and 2.2-fold higher in uninduced and T/B-induced ΔmiRNA cells, respectively, than in wild-type cells (Fig. 1d) . Positive staining for the early viral lytic protein ORF59 was observed 3.1-and 4.6-fold more in uninduced and T/B-induced ΔmiRNA cells, respectively, than wild-type cells (Fig. 1e) . Consistent with these results, ΔmiRNA cells produced 2.4-fold more viral particles than wild-type cells did after lytic induction (Fig. 1f) . This enhanced effect on viral lytic replication following the deletion of the miRNA cluster was specific because the level of viral replication in ΔmiRNA_rt cells was reverted to that in wild-type cells as reflected by RTA and MCP expression levels (Fig. 1g) . Furthermore, stable expression of the miRNA cluster in ΔmiRNA cells, which resulted in the expression of miRNAs at levels similar to those in wild-type cells ( Supplementary Information, Fig. S3a) , reduced the RTA level by 50% and 41% in uninduced and T/B-induced cells, respectively (Fig. 1h) , indicating that the cluster could function in trans. Similar results were observed with MCP. Together, these results indicate that the miRNA cluster inhibits expression of viral lytic genes in latent cells, and in cells induced for viral lytic replication.
In a previous study 15 , computational analysis predicted several putative targeting sites for KSHV miR-K6 in the 3´UTRs of RTA and ZTA, which shared multiple polycistronic transcripts with the same 3´UTR sequences 16 . However, we failed to detect any effects of KSHV miRNAs on these transcripts in 3´UTR reporter assays ( Supplementary Information, Fig. S4 ). As the NF-κB pathway mediates vFLIP inhibition of KSHV lytic replication 17 , we determined the NF-κB status in ΔmiRNA cells. NF-κB activity was 2.2-fold weaker in ΔmiRNA than in wild-type cells in a reporter assay (Fig. 2a) . Although NF-κB activity was increased 3.6-fold in wild-type cells after T/B induction, it remained 1.8-fold lower in ΔmiRNA cells than in wild-type cells. Consistent with these results, in a gel shift assay, a weaker DNA-NF-κB complex band was detected in ΔmiRNA than in wild-type cells with or without lytic induction (Fig. 2b, c) . This band was abolished from three (b-h) or five (a) independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. WT, wild-type; Vector, empty vector.
by a specific competitor and was supershifted by antibodies against cRel, p50 and p65 but not a control antibody, confirming it to be a cRel-p50-p65 NF-κB complex. Furthermore, ΔmiRNA cells had substantially less p65 nuclear staining than wild-type cells (Fig. 2d) . Although T/B treatment increased p65 nuclear staining in both cell types, staining of ΔmiRNA cells remained weaker than that of wild-type cells. Similar results were also observed with p50 and cRel ( Supplementary Information, Fig. S5 ). Thus, NF-κB activity was lower in ΔmiRNA cells than in wild-type cells.
We then determined whether the miRNA cluster could function in trans to regulate NF-κB activity. Expression of the miRNA cluster increased NF-κB activity by 2.1-fold in ΔmiRNA cells (Fig. 2e) . Although T/B induction increased NF-κB activity by 4.8-fold in ΔmiRNA cells, the miRNA cluster increased it a further 1.3-fold. Similar results were observed in wild-type cells though these cells had higher basal NF-κB activity. Expression of the miRNA cluster alone in uninduced and T/Binduced KSHV-negative cells also increased NF-κB activity by 2.0-and Wild-type cells had stronger p65 staining in nuclei identified by DAPI than ΔmiRNA cells (white arrows). (e) NF-κB reporter activities in mock, wild-type and ΔmiRNA cells co-transfected with an miRNA cluster expression vector for 36 h. Induced cells were treated with T/B for 6 h before cell collection. (f, g) Levels of RTA (f) and MCP (g) transcripts examined by real-time qRT-PCR in ΔmiRNA cells transfected with an miRNA cluster expression vector alone or together with an NF-κB dominant-negative (DN) plasmid, pIκB-αM, for 72 h. T/B induction was carried out for 48 h before cell collection. Data are the mean ± s.e.m. of three (e-g) or four (a) independent experiments. For image panels, representative images from two (b, c) or four (d) independent experiments are presented. *P < 0.05, **P < 0.01, ***P < 0.001. WT, wildtype; Vector, empty vector.
1.4-fold, respectively. These results indicate that the miRNA cluster not only rescues NF-κB activity in ΔmiRNA cells but is also itself sufficient to enhance NF-κB activity in KSHV-negative cells.
Next, we determined whether the NF-κB pathway mediates miRNA cluster inhibition of viral replication. Although the miRNA cluster suppressed RTA and MCP expression, this effect was reversed by a mutant Vector miR-K1 of the NF-κB complex inhibitor IκB-α (NF-κB dominant-negative, DN) in both uninduced and T/B-induced ΔmiRNA cells (Fig. 2f, g ). NF-κB DN also increased the expression of RTA and MCP in uninduced and T/B-induced wild-type and ΔmiRNA cells ( Supplementary Information,  Fig. S6 ). Thus, we concluded that inhibition of the NF-κB pathway enhances viral lytic replication, and that the suppression of viral lytic replication by the miRNA cluster can be mediated by this pathway.
To identify the target that mediated miRNA cluster suppression of the NF-κB pathway, we examined IKK (IκB kinase) family members. Consistent with NF-κB activity (Fig. 2b) , IKKα, IKKβ and IKKγ protein levels were higher in wild-type than in uninfected (mock) cells (Fig. 3a) . However, the levels of these IKK proteins in ΔmiRNA cells were at least comparable to or slightly higher than in wild-type cells (Fig. 3a) albeit they had lower NF-κB activity (Fig. 2a-d) , indicating that the reduced NF-κB activity in ΔmiRNA cells was unlikely to have been mediated by the IKK family members. Upon T/B induction, the levels of all three proteins were increased but were similar among the three cell types (Fig. 3a) , reflecting the stimulating effect of T/B on the NF-κB pathway.
We further examined the IκB family members. The level of IκBβ protein was reduced in wild-type and ΔmiRNA cells (Fig. 3a) , which was consistent with their levels of NF-κB activity (Fig. 2b) . Upon T/B induction, expression of IκBβ protein was further reduced, but to comparable levels among the three cell types (Fig. 3a) . Constitutive activation of NF-κB activity can increase the levels of IκBα and IκBε through a feedback loop 18, 19 . Indeed, we detected higher IκBε levels in both wild-type and ΔmiRNA cells than in mock cells (Fig. 3a) . T/B induction increased the IκBε levels in all three cell types. In contrast to IκBε, the level of IκBα in wild-type cells was almost the same as in mock cells (Fig. 3a) , suggesting that IκBα was suppressed by another factor(s). Deletion of the miRNA cluster significantly increased the IκBα level by 1.51-fold (Fig. 3a) . Whereas the IκBα level was reduced in all three cell types after T/B induction, the IκBα level in ΔmiRNA cells remained 2.82-fold higher than in wild-type cells. These results indicated that IκBα might be a target of the miRNA cluster. Indeed, overexpression of the miRNA cluster in KSHV-infected BCP-1 PEL cells 20 reduced the IκBα protein level by 63% in uninduced cells and 73% in T/B-induced cells (Fig. 3b) . In contrast, under the same condition, the levels of IκBε were only marginally affected by the miRNA cluster, with a reduction of 12% and 11%, respectively (Fig. 3b) . Consistent with these results, overexpression of the miRNA cluster in BCP-1 cells increased NF-κB activity by 3.0-and 1.97-fold in uninduced and T/B-induced cells, respectively (Fig. 3c) . To further confirm that IκBα is targeted by the miRNA cluster, we performed a reporter assay with a IκBα 3´UTR reporter. As shown in Fig. 3d , the IκBα 3´UTR reporter activity was 2.5-fold higher in ΔmiRNA cells than in wild-type cells. Furthermore, the miRNA cluster could function in trans in ΔmiRNA cells to reduce the reporter activity by as much as 50% (Fig. 3e) . Thus, the miRNA cluster directly targeted the IκBα 3´UTR.
We used the 3´UTR reporter assay to screen the 14 miRNAs in the cluster, and identified miR-K1 as the miRNA that targeted IκBα ( Supplementary  Information, Fig. S7a ). As shown in Fig. 3f , miR-K1 reduced the IκBα 3´UTR reporter activity by 30% whereas neither miR-K3 nor miR-K11 decreased the activity of the reporter. The miRNA expression constructs were functional, as they suppressed the activities of their sensor reporters containing sequences perfectly matching their respective miRNAs ( Supplementary Information, Fig. S7b ). The suppressive effect of miR-K1 on the IκBα 3´UTR reporter activity grew with its increasing expression level ( Fig. 3g; Supplementary Information, Fig. S3b ). Whereas deletion of the miRNA cluster from the KSHV genome increased the IκBα 3´UTR reporter activity (Fig. 3d) , expression of miR-K1 in ΔmiRNA cells, which resulted in an miR-K1 expression level similar to that in wild-type cells ( Supplementary Information, Fig. S3c ), reversed the trend and reduced the reporter activity by 35% (Fig. 3h) .
The interaction of a miRNA with its target is primarily mediated by a 6 to 7-bp seed sequence at the 5´ end of the miRNA 21 . We identified two putative miR-K1-binding sites (S1 and S2) in the IκBα 3´UTR, using miRNA target prediction software (Fig. 3i) 
22
. Deletion of both sites from the IκBα 3´UTR totally abolished the inhibitory effect of miR-K1 on the reporter whereas deletion of any one site had no detectable effect (Fig. 3j) . We further generated reporters with different tandem repeats of the sites. As shown in Fig. 3k , the inhibitory effect of miR-K1 on the reporters increased with the number of the repeats for both sites, reaching 70% and 67% for S1 and S2, respectively, when reporters containing three repeats of the binding sites were examined. Furthermore, expression of miR-K1 with or without the viral genome significantly reduced the IκBα protein level (Fig. 3l, m;  Supplementary Information, Fig. S8 ). These results clearly indicate that miR-K1 suppresses IκBα protein by directly targeting its 3´UTR.
The identification of miR-K1 as the miRNA targeting IκBα indicated that it should regulate the NF-κB pathway. Indeed, expression of miR-K1 enhanced NF-κB activity in a dose-dependent fashion ( Fig. 4a; Supplementary  Information, Fig. S3b ). While deletion of the miRNA cluster reduced NF-κB activity in KSHV-infected cells (Fig. 2a) , expression of miR-K1 was sufficient to rescue NF-κB activity (Fig. 4b) . We further inhibited the function of miR-K1 in KSHV-infected PEL cells using a locked nucleic acids/ DNA-mixed oligonucleotide (an miR-K1 suppressor), which resulted in a 40% reduction in NF-κB activity (Fig. 4c) . In contrast, we observed minimal effects on NF-κB activity when a miR-K3 or miR-K8 suppressor was used (Fig. 4c) . As expected, the suppressors reduced the levels of their respective miRNAs by 82-99% (Fig. 4d) . Furthermore, the miR-K1 suppressor efficiently relieved the inhibitory effect of miR-K1 on the activity of its sensor reporter by 1.74-fold (Fig. 4e) and significantly increased the IκBα protein level (Fig. 4f) , indicating that it was fully functional.
Finally, we examined the role of miR-K1 in viral lytic replication. Whereas deletion of the miRNA cluster enhanced viral lytic replication, as reflected by increased expression levels of RTA and MCP (Fig. 1a-c) , expression of miR-K1 reversed the trend, and reduced the levels of RTA and MCP transcripts by 68% and 46%, respectively, in uninduced ΔmiRNA cells, and by 65% and 38%, respectively, in T/B-induced ΔmiRNA cells (Fig. 4g, h) . Consistently, the miR-K1 suppressor increased expression of RTA and MCP transcripts in BCP-1 cells by 2.3-and 2.6-fold, respectively and, after T/B induction, by 1.5-and 1.4-fold, respectively (Fig. 4i, j) . In contrast, we observed minimal effects on expression of RTA and MCP transcripts when an miR-K3 or miR-K8 suppressor was used (Fig. 4i, j) . The miR-K1 suppressor also increased expression of the lytic protein ORF59 from 2.4% to 8.2% (3.4-fold) in uninduced PEL cells, and from 9.7% to 23% (2.4-fold) after T/B induction (Fig. 4k, l) . In northern hybridization, the miR-K1 suppressor increased expression of the Pan transcript (one of the most abundant viral lytic transcripts) by 3.7-and 3.2-fold, and the ORF57 transcript (another viral lytic transcript) by 2.6-and 2.1-fold, in uninduced and T/B-induced PEL cells, respectively (Fig. 4m) . These results clearly demonstrate that miR-K1 suppresses viral lytic replication.
Several recent studies have shown that miRNAs of herpesviruses suppress viral replication by directly targeting viral genes 15, [23] [24] [25] [26] . Our results show that KSHV encodes an miRNA to suppress viral replication by regulating the cellular NF-κB pathway. Thus, herpesviruses appear to exploit the miRNA-mediated suppression pathway as a common mechanism to inhibit viral replication and regulate latency. Both vFLIP and LANA also regulate KSHV replication 17, 27, 28 . Hence, KSHV has evolved several mechanisms to suppress viral lytic replication to achieve latency (Fig. 4n) . The NF-κB pathway regulates innate and adaptive immunity, cell survival and inflammation 29 . Oncogenic γ-herpesviruses use multiple strategies to regulate NF-κB activity. Both Epstein-Barr virus (EBV) LMP1 and KSHV vFLIP activate the NF-κB pathway to promote cell growth and survival, and to contribute to viral latency [30] [31] [32] . Our results support a general role of the NF-κB pathway in regulating the latency of γ-herpesviruses through two interrelated mechanisms, by inhibiting viral replication and by promoting cell survival (Fig. 4n) .
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Construction of ΔmiRNA and ΔmiRNA_rt. The procedures for generating a KSHV mutant with a cluster of 14 KSHV miRNAs (except miR-K10a/b and miR-K12) deleted (ΔmiRNA) and its revertant (ΔmiRNA_rt) were described previously 13 . The strategy is illustrated in Supplementary Information, Fig. S1a . We first obtained a PCR product with primers 5´-TTGAATACAGTTGGGGGTAGTCCGCTGG-TATTCCCAGCTGAGGTTGCCTTAGTGTAGGCTGGAGCTGCTTC-3´ and 5´-GTGCTTCTGTTTGAAGGCGAATAAAACAGGAAGCGGGTTGGACT-GGCAGGGTCATATGAATATCCTCCTTAG-3´ using plasmid pMS102-Zeocin as a template. This PCR fragment contained a zeocin-resistance cassette (Zeo R ) flanked by loxP sites and 50 bp sequences from the two ends of the miRNA cluster (genomic position: 122,055 and 119,161). The product was electroporated into E. coli strain DH10B containing the wild-type virus BAC36 (wild-type) and the helper plasmid pGET-rec to facilitate homologous recombination. Zeocin-resistant colonies containing KSHV genomes with the miRNA cluster deleted and replaced by the Zeo R were selected. To remove the Zeo R , a Cre-expression plasmid pCTP-T carrying a tetracycline-resistance gene (Tc R ), a temperature sensitive origin of replication and the Cre recombinase gene under the control of the tetracycline-responsive promoter, was introduced into the zeocin-resistant bacteria by transformation. The bacteria were then cultured in LB media with tetracycline at 50 μg ml -1 for 3 h at 30 °C to allow Cre expression and site-specific recombination between the two LoxP sites, resulting in the excision of the Zeo R . The tetracycline-resistant colonies were selected and verified for the presence of KSHV genome and removal of the Zeo R . The Cre-expression plasmid was eliminated by culturing the bacteria at 42 °C.
The revertant ΔmiRNA_rt was generated in two steps using ΔmiRNA as a template. First, two PCR products were generated. One product was obtained using primers 5´-ATACTCGAGGTGTAGGCTGGAGCTGCTTC-3´ and 5´-GTATCTGATTTAATAAACACTAACAAGTTTTGTAAGAATCATTA-GAATGCCATATGAATATCCTCCTTAG-3´, and pMS102-Zeocin as a template. This fragment contained the Zeo R flanked by LoxP sites together with a fragment of 50 bp KSHV sequence (genome position: 122056-122106) at one end and an XhoI restriction site at the other end. A second product was obtained using primers 5´-GACCCAGCTGGTTTCCATAAATGGATATACTTCCG-GAAAACGAAGGAGGG-3´ and 5´-ATACTCGAGGTGCTTCTGTTTGAAG-GCGAATAAAACAGGAAGCGGGTTGGACTGGCAGGGT-3´, and BAC36 DNA as a template. This product contained the sequence of the entire miRNA cluster with an XhoI site at one end. Second, these two PCR products were ligated after XhoI digestion, resulting in a cassette containing the miRNA cluster and Zeo R , which was then electroporated into E. coli DH10 containing ΔmiRNA. Selection of colonies containing KSHV genomes with the miRNA cluster repaired followed by excision of the Zeo R led to the generation of ΔmiRNA _rt.
Cell culture and virus induction.
Human embryonic kidney 293T cells were cultured in Dulbecco' s modified Eagle' s medium with 10% fetal bovine serum (FBS). For stable selection of cultures of recombinant viruses, hygromycin at 200 μg ml -1 was added to the media. KSHV-infected primary effusion lymphoma (PEL) BCP-1 cells 20 were cultured in RPMI-1640 with 10% of FBS. To induce viral lytic replication, cells were treated with 20 ng ml -1 of TPA and 0.25 mM sodium butyrate (T/B) for the specified lengths of time. To determine virion production, supernatants from cells induced for 5 days were collected and filtered through 0.45-μm filters. Virions were pelleted by ultracentrifugation, treated sequentially by Turbo DNAase I (Ambion) and proteinase K. Virion DNA was determined by real-time quantitative PCR (qPCR) following DNA extraction. Purified BAC36 DNA was used as a copy number control.
Real-time quantitative reverse transcription-PCR (RT-qPCR).
Total RNA isolated with Trizol reagent (Invitrogen) was treated with DNase I. qRT-PCR for KSHV genes was carried out as described previously 33 . Real-time quantification of miRNAs was carried out by stem-loop qRT-PCR
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. A reverse transcriptase reaction was first carried out by incubating the RNA sample with a stem-loop RT primer for 30 min at 16 °C, 30 min at 42 °C, 5 min at 85 °C and then held at 4 °C. qPCR was performed on a 7700HT Sequence Detection System (Applied Biosystems). The reactions were carried out in a 96-well plate at 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s, and then 60 °C for 1 min. All the reactions were run in triplicates. The differences of cycle threshold values (C T ) between the samples (ΔC T ) were calculated after calibration with GAPDH and converted to fold changes using one of the samples as a standard (1-fold). The primers used in qRT-PCR are listed in Supplementary Information, Table S1 .
Plasmids. KSHV RTA promoter-luciferase reporter plasmid was described previously 35 . NF-κB reporter plasmid, containing tandem repeats of consensus NF-κB binding sites, was obtained from B. Sudgen (University of Wisconsin-Madison, WI, USA). NF-κB DN plasmid pIκB-αM was provided by P. J. Chiao (University of Texas M.D. Anderson Cancer Center, TX, USA). The construction of IκBα 3´UTR luciferase reporter plasmid IκBα3UTRluc (IκBα wild-type) was carried out by inserting the full-length of the IκBα 3´UTR sequence downstream of the luciferase sequence into the pGL3 vector. miR-K1 targeting sites were identified with target prediction software miRanda 22 . Deletions of the two putative miR-K1-binding sites S1 and S2 from the IκBα 3´UTR were performed by site-directed mutagenesis using primers 5´-GTGGTACATGTAACAGCCAGGAGTGTTAAGCGTTC-3´ and 5´-TACATGTACCACTGGGGTCAGTCACTCGAAGC-3´ for site 1, and primers 5´-GTTACCCATGGTGTACATAATGTATTGTTGG-3´ and 5´-TACACCATGGGTAACACAAACCTTGACAGG-3´ for site 2 (Fig. 3i) . Corresponding reporters were named IκBα3UTRlucΔS1 (ΔS1), IκBα3UTRlucΔS2 (ΔS2), IκBα3UTRlucΔS1+2 (ΔS1+2), respectively. Reporters containing different numbers of tandem repeats of the miR-K1 binding sites were generated by fusing the repeats through HindIII sites and cloning the products into the pGL3 vector. To construct 3´UTR luciferase reporter plasmids of RTA and ZTA type I, II and III transcripts 16 , we inserted their full-length 3´UTR sequences into the pGL3 vector downstream of the luciferase sequence between KpnI and XhoI sites after PCR amplification of cDNAs with the following primers RTA3´UTR-KpnI-F: 5´-TTTTGGTACCAGTGTTCGCAAGGGCGTCTGTGCCT-3´ and RTA3´UTR-XhoI-R: 5´-TCTC CTCGAGGTAGGGTTTCTTACGCCGGCATCGT-3´. Sequences of RTA and ZTA transcripts were based on AF091348, AF091349 and AF091350. To express the miRNA cluster or individual KSHV miRNAs, the whole cluster or individual miRNA fragments were cloned by PCR amplification as described previously 36 , and inserted between BglII and HindIII sites of an expression vector pSUPER.retro.puro (OligoEngine). The sensor plasmids for KSHV miRNAs containing two repeats of perfect matching sequences of the respective miRNAs were described previously 36 .
Reporter assays. The luciferase reporter constructs and β-galactosidase expression plasmid pSV-β-Gal (Promega) were co-transfected into cells cultured in 24-well plates using the F2 transfection reagent (Targeting Systems). For induction, cells transfected for 24 h were treated with T/B for 12 h. Other reporter assays were performed with the indicated expression plasmids and lengths of transfection time. Cells were then lysed, and the luciferase and β-Gal activities were measured using luciferase and β-galactosidase kits (Promega). Luciferase activity was normalized to β-galactosidase activity. Results were calculated as the mean ± s.e.m. from at least three independent experiments, each in triplicates except Fig. 4a , for which the means were calculated from two independent experiments, each in triplicates.
Western blotting. Protein samples were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes as described previously 37 . The membranes were first blocked with 5% non-fat milk and then incubated with a primary antibody followed with a horseradish peroxidase (HRP)-conjugated secondary antibody (Sigma, Life Science). Specific bands were revealed with chemiluminescence substrates (Roche) and recorded with an IS2000MM Imaging Scanner (Eastman Kodak Company). Antibodies against the following proteins were used: IKKα, IKKβ, IKKγ, IκBα, IκBβ and IκBε, all from GeneTex (San Antonio), and β-Tubulin (Sigma).
Immunofluorescence assay. Cells grown on coverslides were first fixed with methanol or 1% paraformaldehyde, and blocked with 10% FBS. Cells were then incubated with a primary antibody, and specific signal was detected with a secondary antibody conjugated with Alexa Fluor 568 (Invitrogen). The cells were counterstained with 4´, 6´-diamidino-2-phenylindole (DAPI). Images were observed and recorded with a Zeiss Axiovert 200 M epifluorescence microscope (Carl Zeiss, Inc.). Antibodies against p65, p50 and cRel (Calbiochem), ORF59 (a gift from B. Chandran, Rosalind Franklin University of Medicine and Science, IL, USA) and LANA (ABI) were used.
Electrophoretic mobility shift assay (EMSA). Nuclear extracts were prepared as described previously 35 . Annealed double-stranded oligonucleotides containing a NF-κB consensus site (5´-AGTTGAGGGACTTTCCTT-3´) were labelled with [γ- 
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